IP_logo    fiocruzminiatura(claro)TDR_logo

The Key Role of DNDi’s Founding Partners

Since DNDi’s founding in 2003, seven key stakeholders have helped to propel the initiative. Each of DNDi’s original Board Members represents one of DNDi’s Founding Partners, all of which are centres of excellence in neglected disease research and/or patient care. Drawn primarily from the public sector in neglected disease-endemic countries, they have continued to serve as the backbone of DNDi by providing their expert advice, the benefit of their experience, and key project participation.

DNDi’s Founding Partners are:

Established in 1911, it was re-designated in 1949 as the Indian Council of Medical Research (ICMR). Funded by the Government of India, ICMR’s activities are focused on the formulation, coordination, and promotion of biomedical research. The Council has a network of 21 Permanent Research Institutes located in different parts of India that conduct research on tuberculosis, leprosy, and visceral leishmaniasis. www.icmr.nic.in

IP_logoEstablished in France in 1887, the Institut Pasteur is a private, non-profit foundation dedicated to the prevention and treatment of diseases. It focuses on diseases like yellow fever, tuberculosis, poliomyelitis, hepatitis, and HIV/AIDS. With eight Nobel Prizes awarded to its researchers, the Institut Pasteur is on the forefront of medical research with discoveries of antitoxins, BCG, sulfamides, and antihistamines, as well as key research in molecular biology and genetic engineering. www.pasteur.fr

Established in 1979, KEMRI conducts health sciences research and shares its research findings with the international community. One of the leading health research institutions in Africa, KEMRI has and continues to make a significant contribution to regional research capacity, with a focus on infectious and parasitic diseases, and on public health and biotechnology research. www.kemri.org

 

MSF is an independent, private, medical aid organisation that has been operational in emergency medical aid missions around the world since 1971. With offices in 22 countries and ongoing activities in 63, MSF has also run the Campaign for Access to Essential Medicines since 1999. MSF has received numerous international awards for its activities, including the Nobel Peace Prize in 1999. MSF dedicated this prize to finding long-term, sustainable solutions to the lack of essential medicines crisis (which ultimately led to the founding of DNDi in 2003). www.msf.org

The Institute for Medical Research (IMR), within the Ministry, was established in 1900 to carry out scientific and sustained research into the causes, treatment, and prevention of infectious tropical diseases. Initially, it focused on malaria, beriberi, cholera, and dysentery. The IMR is now comprised of eight centres which perform research, diagnostic services, training, and consultative services across diverse health fields. www.imr.gov.my; www.moh.gov.my

 

Founded in 1900, Fiocruz is the largest biomedical research institution in Latin America. Part of the Brazilian Ministry of Health, Fiocruz has facilitated health tool R&D for neglected diseases via the establishment of dedicated centres for vaccine and drug development: Biomanguinhos and Farmanguinhos. Farmanguinhos/Fiocruz, one of the largest pharmaceutical laboratories in Brazil, has a long history of drug production in the field of neglected diseases, particularly for AIDS and for malaria with the development of the ASMQ treatment. www.fiocruz.br

 

TDR_logoAs an independent global programme of scientific collaboration, established in 1975 and co-sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development  Programme (UNDP), the World Bank, and the World Health Organization (WHO), TDR aims to help coordinate, support, and influence global efforts to combat a portfolio of major diseases of the poor and disadvantaged. TDR is a permanent observer of DNDi’s Board of Directors. www.who.int/tdr